We help clients allocate R&D resources and optimize the value of assets in their development pipeline across a variety of specialties, including oncology. We design the focus for adoption of digital and data analytics to improve R&D efficiency, including the use of virtual trials and AI to discover new drugs.

EC works with clients to develop commercial approaches that are customized to provider and patient needs. Together, we help maximize new product launches, support pricing strategies, and develop sales and marketing initiatives based on market and customer insights.

We help companies develop and scale digital technologies, and make better use of better data. Improving data management tool with human centric design. Healthcare being a knowledge instense industry, it is imperative to hire agencies that has experience and lead by physicians. 

Volatile commodity prices and industry market valuations are forcing MSME operators to cut costs, limit capital expenditures, and boost productivity. The size and speed of profitability improvements largely depends on commodity, region, and specific source of supply.

Diorama helps organizations define their strategy by identifying opportunities, improving financial planning, and benchmarking performances. Diorama answers key questions such as: How big are certain markets? What is the profitability of certain product lines?

Imagine subscribing to a factory. Instead of owning facilities that manufacture its products, a producer pays a usage fee to share a highly flexible factory with other companies. To make the arrangement financially attractive, third-party investors own the assets. In a nutshell, this is the concept called “Manufacturing as a Service” (MaaS).

We help organizations create a modular, microservice-like architecture for data modeling, and create and maintain data models to answer business questions in fields such as: Finance Analytics, Marketing Analytics, Product Analytics, Customer Analytics, Executive Reporting.

RLS is a powerful analytics platform that combines and organizes data, integrating industry-standard key indicators to create a single source of truth and transparency—which makes testing outcomes and identifying problems, and the possible solutions, efficient and effective.

Helping companies capture opportunities across the value chain for generics, branded generics, established products and biosimilars, and forging connections among industry stakeholders.

Helping clients build the R&D capabilities needed to drive innovation, improve productivity and performance, and develop successful portfolio and asset strategies.

Helping health tech businesses across the entire value chain, from start-ups in the initial stages of fundraising to established companies, expand into global markets.